Rathbones Group PLC Merck & Co., Inc. Transaction History
Rathbones Group PLC
- $19.7 Billion
- Q1 2025
A detailed history of Rathbones Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 497,806 shares of MRK stock, worth $41.8 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
497,806
Previous 1,262,015
60.55%
Holding current value
$41.8 Million
Previous $126 Million
64.41%
% of portfolio
0.23%
Previous 0.64%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,886Shares Held
1.93BCall Options Held
25.6MPut Options Held
24M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.1 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.87 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$5.01 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...